Less Than 5% Of Cancer Patients Get Access To Clinical Trials

Forbes.com, September 20, 2023

C4C’s Dr. Bob Li discusses the need for a greater focus on global inequity, defined as a lack of access to clinical trials and breakthrough research. Today, only less than 5% of cancer patients have access to clinical trials offering potentially life-saving new drugs and treatment breakthroughs.